subject: UNII:K16AIQ8CTM

object_name: Oesophageal carcinoma recurrent


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: Cervix carcinoma recurrent

tested_intervention: unsure


subject: UNII:K16AIQ8CTM

object_name: exocrine pancreatic carcinoma


subject: UNII:K16AIQ8CTM

object_name: recurrent gastric cancer


subject: UNII:K16AIQ8CTM

object_name: Bladder cancer recurrent


subject: UNII:K16AIQ8CTM

object_name: Recurrent Liver Carcinoma


subject: UNII:K16AIQ8CTM

object_name: Recurrent Unspecified Lung Carcinoma


subject: UNII:K16AIQ8CTM

object_name: Recurrent Skin Carcinoma


subject: UNII:K16AIQ8CTM

object_name: thyroid gland carcinoma


subject: UNII:K16AIQ8CTM

object_name: colorectal carcinoma


subject: UNII:K16AIQ8CTM

object_name: Melanoma recurrent


subject: UNII:K16AIQ8CTM

object_name: rectal carcinoma


subject: UNII:K16AIQ8CTM

object_name: Recurrent Glioma


subject: UNII:K16AIQ8CTM

object_name: suppressor of tumorigenicity 3


subject: UNII:K16AIQ8CTM

object_name: cervical carcinoma


subject: UNII:K16AIQ8CTM

object_name: prostate carcinoma

tested_intervention: yes


subject: UNII:K16AIQ8CTM

object_name: malignant epithelial tumor of ovary


subject: UNII:K16AIQ8CTM

object_name: renal carcinoma


subject: UNII:K16AIQ8CTM

object_name: renal cell carcinoma


subject: UNII:K16AIQ8CTM

object_name: liver carcinoma


subject: UNII:K16AIQ8CTM

object_name: colon carcinoma


subject: UNII:K16AIQ8CTM

object_name: lung carcinoma


subject: UNII:K16AIQ8CTM

object_name: skin carcinoma


subject: UNII:K16AIQ8CTM

object_name: melanoma


subject: UNII:K16AIQ8CTM

object_name: glioma


subject: UNII:K16AIQ8CTM

object_name: malignant glioma


subject: UNII:AF75XOF6W3

subject_name: Relatlimab

object_name: plasma cell myeloma


subject: UNII:AF75XOF6W3

object_name: adult lymphoma


subject: UNII:AF75XOF6W3

object_name: lymphoma


subject: UNII:AF75XOF6W3

object_name: pediatric lymphoma


subject: UNII:AF75XOF6W3

object_name: Plasma cell myeloma recurrent


subject: UNII:AF75XOF6W3

object_name: Recurrent Lymphoma


subject: UNII:AF75XOF6W3

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:AF75XOF6W3

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:AF75XOF6W3

object_name: Recurrent Malignant Solid Neoplasm


subject: UNII:AF75XOF6W3

object_name: Pancreatic carcinoma recurrent


subject: UNII:AF75XOF6W3

object_name: Recurrent Rectal Cancer


subject: UNII:AF75XOF6W3

object_name: Recurrent Head and Neck Carcinoma


subject: UNII:AF75XOF6W3

object_name: Recurrent Thyroid Carcinoma


subject: UNII:AF75XOF6W3

object_name: Neck Carcinoma


subject: UNII:AF75XOF6W3

object_name: uterine corpus cancer


subject: UNII:AF75XOF6W3

object_name: Prostate cancer recurrent


subject: UNII:AF75XOF6W3

object_name: endometrial carcinoma


subject: UNII:AF75XOF6W3

object_name: uterine cancer


subject: UNII:AF75XOF6W3

object_name: Breast cancer recurrent


subject: UNII:AF75XOF6W3

object_name: Colorectal cancer recurrent


subject: UNII:AF75XOF6W3

object_name: Recurrent ovarian cancer


subject: UNII:AF75XOF6W3

object_name: Oesophageal carcinoma recurrent


subject: UNII:AF75XOF6W3

object_name: Cervix carcinoma recurrent


subject: UNII:AF75XOF6W3

object_name: exocrine pancreatic carcinoma


subject: UNII:AF75XOF6W3

object_name: recurrent gastric cancer


subject: UNII:AF75XOF6W3

object_name: Bladder cancer recurrent


subject: UNII:AF75XOF6W3

object_name: Recurrent Liver Carcinoma


subject: UNII:AF75XOF6W3

object_name: Colon cancer recurrent


subject: UNII:AF75XOF6W3

object_name: Recurrent Unspecified Lung Carcinoma


subject: UNII:AF75XOF6W3

object_name: Recurrent Skin Carcinoma


subject: UNII:AF75XOF6W3

object_name: thyroid gland carcinoma


subject: UNII:AF75XOF6W3

object_name: breast carcinoma


subject: UNII:AF75XOF6W3

object_name: Melanoma recurrent


subject: UNII:AF75XOF6W3

object_name: rectal carcinoma


subject: UNII:AF75XOF6W3

object_name: rectum adenocarcinoma


subject: UNII:AF75XOF6W3

object_name: Recurrent Glioma


subject: UNII:AF75XOF6W3

object_name: suppressor of tumorigenicity 3


subject: UNII:AF75XOF6W3

object_name: cervical carcinoma


subject: UNII:AF75XOF6W3

object_name: prostate carcinoma


subject: UNII:AF75XOF6W3

object_name: ovarian cancer


subject: UNII:AF75XOF6W3

object_name: ovarian carcinoma


subject: UNII:AF75XOF6W3

object_name: malignant epithelial tumor of ovary


subject: UNII:AF75XOF6W3

object_name: urinary bladder carcinoma


subject: UNII:AF75XOF6W3

object_name: renal carcinoma


subject: UNII:AF75XOF6W3

object_name: colon carcinoma


subject: UNII:AF75XOF6W3

object_name: lung carcinoma


subject: UNII:AF75XOF6W3

object_name: skin carcinoma


subject: UNII:AF75XOF6W3

object_name: glioma


subject: UNII:AF75XOF6W3

object_name: malignant glioma


subject: UMLS:C3827149

object_name: plasma cell myeloma


subject: UMLS:C3827149

object_name: adult lymphoma


subject: UMLS:C3827149

object_name: lymphoma


subject: UMLS:C3827149

object_name: pediatric lymphoma


subject: UMLS:C3827149

object_name: Plasma cell myeloma recurrent


subject: UMLS:C3827149

object_name: Recurrent Lymphoma


subject: UMLS:C3827149

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C3827149

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C3827149

object_name: Recurrent Malignant Solid Neoplasm


subject: UMLS:C3827149

object_name: Pancreatic carcinoma recurrent


subject: UMLS:C3827149

object_name: Recurrent Rectal Cancer


subject: UMLS:C3827149

object_name: Recurrent Head and Neck Carcinoma


subject: UMLS:C3827149

object_name: Recurrent Thyroid Carcinoma


subject: UMLS:C3827149

object_name: Neck Carcinoma


subject: UMLS:C3827149

object_name: uterine corpus cancer


subject: UMLS:C3827149

object_name: Prostate cancer recurrent


subject: UMLS:C3827149

object_name: endometrial carcinoma


subject: UMLS:C3827149

object_name: uterine cancer


subject: UMLS:C3827149

object_name: Breast cancer recurrent


subject: UMLS:C3827149

object_name: Colorectal cancer recurrent


subject: UMLS:C3827149

object_name: Recurrent ovarian cancer


subject: UMLS:C3827149

object_name: Oesophageal carcinoma recurrent


subject: UMLS:C3827149

object_name: Cervix carcinoma recurrent


subject: UMLS:C3827149

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3827149

object_name: recurrent gastric cancer


subject: UMLS:C3827149

object_name: Bladder cancer recurrent


subject: UMLS:C3827149

object_name: Recurrent Liver Carcinoma


subject: UMLS:C3827149

object_name: Colon cancer recurrent


subject: UMLS:C3827149

object_name: Recurrent Unspecified Lung Carcinoma


subject: UMLS:C3827149

object_name: Recurrent Skin Carcinoma


subject: UMLS:C3827149

object_name: thyroid gland carcinoma


subject: UMLS:C3827149

object_name: breast carcinoma


subject: UMLS:C3827149

object_name: Melanoma recurrent


subject: UMLS:C3827149

object_name: rectal carcinoma


subject: UMLS:C3827149

object_name: rectum adenocarcinoma


subject: UMLS:C3827149

object_name: Recurrent Glioma


subject: UMLS:C3827149

object_name: suppressor of tumorigenicity 3


subject: UMLS:C3827149

object_name: cervical carcinoma


subject: UMLS:C3827149

object_name: prostate carcinoma


subject: UMLS:C3827149

object_name: ovarian cancer


subject: UMLS:C3827149

object_name: ovarian carcinoma


subject: UMLS:C3827149

object_name: malignant epithelial tumor of ovary


subject: UMLS:C3827149

object_name: urinary bladder carcinoma


subject: UMLS:C3827149

object_name: renal carcinoma


subject: UMLS:C3827149

object_name: colon carcinoma


subject: UMLS:C3827149

object_name: lung carcinoma


subject: UMLS:C3827149

object_name: skin carcinoma


subject: UMLS:C3827149

object_name: glioma


subject: UMLS:C3827149

object_name: malignant glioma


subject: CHEBI:91450

subject_name: Sapanisertib

object_name: plasma cell myeloma


subject: CHEBI:91450

object_name: adult lymphoma


subject: CHEBI:91450

object_name: lymphoma


subject: CHEBI:91450

object_name: pediatric lymphoma


subject: CHEBI:91450

object_name: Plasma cell myeloma recurrent


subject: CHEBI:91450

object_name: Recurrent Lymphoma


subject: CHEBI:91450

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:91450

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:91450

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:91450

object_name: Recurrent Rectal Cancer


subject: CHEBI:91450

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:91450

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:91450

object_name: Neck Carcinoma


subject: CHEBI:91450

object_name: Prostate cancer recurrent


subject: CHEBI:91450

object_name: uterine cancer


subject: CHEBI:91450

object_name: Breast cancer recurrent


subject: CHEBI:91450

object_name: Colorectal cancer recurrent


subject: CHEBI:91450

object_name: Recurrent ovarian cancer


subject: CHEBI:91450

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:91450

object_name: Cervix carcinoma recurrent


subject: CHEBI:91450

object_name: exocrine pancreatic carcinoma


subject: CHEBI:91450

object_name: recurrent gastric cancer


subject: CHEBI:91450

object_name: Bladder cancer recurrent


subject: CHEBI:91450

object_name: Recurrent Liver Carcinoma


subject: CHEBI:91450

object_name: Colon cancer recurrent


subject: CHEBI:91450

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:91450

object_name: Recurrent Skin Carcinoma


subject: CHEBI:91450

object_name: colorectal carcinoma


subject: CHEBI:91450

object_name: Melanoma recurrent


subject: CHEBI:91450

object_name: carcinoma of esophagus


subject: CHEBI:91450

object_name: rectal carcinoma


subject: CHEBI:91450

object_name: rectum adenocarcinoma


subject: CHEBI:91450

object_name: Recurrent Glioma


subject: CHEBI:91450

object_name: suppressor of tumorigenicity 3


subject: CHEBI:91450

object_name: cervical carcinoma


subject: CHEBI:91450

object_name: prostate carcinoma


subject: CHEBI:91450

object_name: Stomach cancer


subject: CHEBI:91450

object_name: ovarian cancer


subject: CHEBI:91450

object_name: ovarian carcinoma


subject: CHEBI:91450

object_name: malignant epithelial tumor of ovary


subject: CHEBI:91450

object_name: urinary bladder carcinoma


subject: CHEBI:91450

object_name: renal carcinoma


subject: CHEBI:91450

object_name: renal cell carcinoma


subject: CHEBI:91450

object_name: liver carcinoma


subject: CHEBI:91450

object_name: colon carcinoma


subject: CHEBI:91450

object_name: lung carcinoma


subject: CHEBI:91450

object_name: skin carcinoma


subject: CHEBI:91450

object_name: melanoma


subject: CHEBI:91450

object_name: glioma


subject: CHEBI:91450

object_name: malignant glioma


subject: CHEBI:38940

subject_name: Sunitinib

object_name: adult lymphoma


subject: CHEBI:38940

object_name: lymphoma


subject: CHEBI:38940

object_name: pediatric lymphoma


subject: CHEBI:38940

object_name: Plasma cell myeloma refractory


subject: CHEBI:38940

object_name: Refractory Lymphoma


subject: CHEBI:38940

object_name: Advanced Lymphoma


subject: CHEBI:38940

object_name: Plasma cell myeloma recurrent


subject: CHEBI:38940

object_name: Recurrent Lymphoma


subject: CHEBI:38940

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:38940

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:38940

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:38940

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:38940

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:38940

object_name: Recurrent Rectal Cancer


subject: CHEBI:38940

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:38940

object_name: Neck Carcinoma


subject: CHEBI:38940

object_name: Prostate cancer recurrent


subject: CHEBI:38940

object_name: uterine cancer


subject: CHEBI:38940

object_name: Breast cancer recurrent


subject: CHEBI:38940

object_name: Colorectal cancer recurrent


subject: CHEBI:38940

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:38940

object_name: Cervix carcinoma recurrent


subject: CHEBI:38940

object_name: recurrent gastric cancer


subject: CHEBI:38940

object_name: Bladder cancer recurrent


subject: CHEBI:38940

object_name: Recurrent Liver Carcinoma


subject: CHEBI:38940

object_name: Colon cancer recurrent


subject: CHEBI:38940

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:38940

object_name: Recurrent Skin Carcinoma


subject: CHEBI:38940

object_name: colorectal carcinoma


subject: CHEBI:38940

object_name: Melanoma recurrent


subject: CHEBI:38940

object_name: rectal carcinoma


subject: CHEBI:38940

object_name: rectum adenocarcinoma


subject: CHEBI:38940

object_name: Recurrent Glioma


subject: CHEBI:38940

object_name: suppressor of tumorigenicity 3


subject: CHEBI:38940

object_name: cervical carcinoma


subject: CHEBI:38940

object_name: malignant epithelial tumor of ovary


subject: CHEBI:38940

object_name: colon carcinoma


subject: CHEBI:38940

object_name: skin carcinoma


subject: CHEBI:38940

object_name: glioma


subject: UNII:L08J2O299M

subject_name: Taselisib

object_name: plasma cell myeloma


subject: UNII:L08J2O299M

object_name: adult lymphoma


subject: UNII:L08J2O299M

object_name: lymphoma


subject: UNII:L08J2O299M

object_name: pediatric lymphoma


subject: UNII:L08J2O299M

object_name: Plasma cell myeloma refractory


subject: UNII:L08J2O299M

object_name: Refractory Lymphoma


subject: UNII:L08J2O299M

object_name: Advanced Lymphoma


subject: UNII:L08J2O299M

object_name: Plasma cell myeloma recurrent


subject: UNII:L08J2O299M

object_name: Recurrent Lymphoma


subject: UNII:L08J2O299M

object_name: Refractory Malignant Solid Neoplasm


subject: UNII:L08J2O299M

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:L08J2O299M

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:L08J2O299M

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:L08J2O299M

object_name: Recurrent Malignant Solid Neoplasm


subject: UNII:L08J2O299M

object_name: Pancreatic carcinoma recurrent


subject: UNII:L08J2O299M

object_name: Recurrent Rectal Cancer


subject: UNII:L08J2O299M

object_name: Recurrent Head and Neck Carcinoma


subject: UNII:L08J2O299M

object_name: Recurrent Thyroid Carcinoma


subject: UNII:L08J2O299M

object_name: Neck Carcinoma


subject: UNII:L08J2O299M

object_name: uterine corpus cancer


subject: UNII:L08J2O299M

object_name: Prostate cancer recurrent


subject: UNII:L08J2O299M

object_name: endometrial carcinoma


subject: UNII:L08J2O299M

object_name: uterine cancer


subject: UNII:L08J2O299M

object_name: Colorectal cancer recurrent


subject: UNII:L08J2O299M

object_name: Recurrent ovarian cancer


subject: UNII:L08J2O299M

object_name: Oesophageal carcinoma recurrent


subject: UNII:L08J2O299M

object_name: Cervix carcinoma recurrent


subject: UNII:L08J2O299M

object_name: exocrine pancreatic carcinoma


subject: UNII:L08J2O299M

object_name: recurrent gastric cancer


subject: UNII:L08J2O299M

object_name: Bladder cancer recurrent


subject: UNII:L08J2O299M

object_name: Recurrent Liver Carcinoma


subject: UNII:L08J2O299M

object_name: Colon cancer recurrent


subject: UNII:L08J2O299M

object_name: Recurrent Unspecified Lung Carcinoma


subject: UNII:L08J2O299M

object_name: Recurrent Skin Carcinoma


subject: UNII:L08J2O299M

object_name: thyroid gland carcinoma


subject: UNII:L08J2O299M

object_name: breast carcinoma


subject: UNII:L08J2O299M

object_name: colorectal carcinoma


subject: UNII:L08J2O299M

object_name: Melanoma recurrent


subject: UNII:L08J2O299M

object_name: carcinoma of esophagus


subject: UNII:L08J2O299M

object_name: rectal carcinoma


subject: UNII:L08J2O299M

object_name: rectum adenocarcinoma


subject: UNII:L08J2O299M

object_name: Recurrent Glioma


subject: UNII:L08J2O299M

object_name: suppressor of tumorigenicity 3


subject: UNII:L08J2O299M

object_name: cervical carcinoma


subject: UNII:L08J2O299M

object_name: prostate carcinoma


subject: UNII:L08J2O299M

object_name: Stomach cancer


subject: UNII:L08J2O299M

object_name: ovarian cancer


subject: UNII:L08J2O299M

object_name: ovarian carcinoma


subject: UNII:L08J2O299M

object_name: malignant epithelial tumor of ovary


subject: UNII:L08J2O299M

object_name: urinary bladder carcinoma


subject: UNII:L08J2O299M

object_name: renal carcinoma


subject: UNII:L08J2O299M

object_name: renal cell carcinoma


subject: UNII:L08J2O299M

object_name: liver carcinoma


subject: UNII:L08J2O299M

object_name: colon carcinoma


subject: UNII:L08J2O299M

object_name: lung carcinoma


subject: UNII:L08J2O299M

object_name: skin carcinoma


subject: UNII:L08J2O299M

object_name: melanoma


subject: UNII:L08J2O299M

object_name: glioma


subject: UNII:L08J2O299M

object_name: malignant glioma


subject: CHEBI:75998

subject_name: Trametinib

object_name: adult lymphoma


subject: CHEBI:75998

object_name: lymphoma


subject: CHEBI:75998

object_name: pediatric lymphoma


subject: CHEBI:75998

object_name: Refractory Lymphoma


subject: CHEBI:75998

object_name: Advanced Lymphoma


subject: CHEBI:75998

object_name: Recurrent Lymphoma


subject: CHEBI:75998

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:75998

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:75998

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:75998

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:75998

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:75998

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:75998

object_name: Neck Carcinoma


subject: CHEBI:75998

object_name: uterine corpus cancer


subject: CHEBI:75998

object_name: Prostate cancer recurrent


subject: CHEBI:75998

object_name: endometrial carcinoma


subject: CHEBI:75998

object_name: uterine cancer


subject: CHEBI:75998

object_name: Breast cancer recurrent


subject: CHEBI:75998

object_name: Colorectal cancer recurrent


subject: CHEBI:75998

object_name: Recurrent ovarian cancer


subject: CHEBI:75998

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:75998

object_name: Cervix carcinoma recurrent


subject: CHEBI:75998

object_name: exocrine pancreatic carcinoma


subject: CHEBI:75998

object_name: recurrent gastric cancer


subject: CHEBI:75998

object_name: Bladder cancer recurrent


subject: CHEBI:75998

object_name: Recurrent Liver Carcinoma


subject: CHEBI:75998

object_name: Colon cancer recurrent


subject: CHEBI:75998

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:75998

object_name: Recurrent Skin Carcinoma


subject: CHEBI:75998

object_name: carcinoma of esophagus


subject: CHEBI:75998

object_name: rectal carcinoma


subject: CHEBI:75998

object_name: rectum adenocarcinoma


subject: CHEBI:75998

object_name: Recurrent Glioma


subject: CHEBI:75998

object_name: suppressor of tumorigenicity 3


subject: CHEBI:75998

object_name: cervical carcinoma


subject: CHEBI:75998

object_name: prostate carcinoma


subject: CHEBI:75998

object_name: Stomach cancer


subject: CHEBI:75998

object_name: ovarian cancer


subject: CHEBI:75998

object_name: ovarian carcinoma


subject: CHEBI:75998

object_name: malignant epithelial tumor of ovary


subject: CHEBI:75998

object_name: urinary bladder carcinoma


subject: CHEBI:75998

object_name: renal carcinoma


subject: CHEBI:75998

object_name: renal cell carcinoma


subject: CHEBI:75998

object_name: liver carcinoma


subject: CHEBI:75998

object_name: lung carcinoma


subject: CHEBI:75998

object_name: skin carcinoma


subject: CHEBI:231601

subject_name: trastuzumab

object_name: adult lymphoma


subject: CHEBI:231601

object_name: lymphoma


subject: CHEBI:231601

object_name: pediatric lymphoma


subject: CHEBI:231601

object_name: Plasma cell myeloma refractory


subject: CHEBI:231601

object_name: Refractory Lymphoma


subject: CHEBI:231601

object_name: Advanced Lymphoma


subject: CHEBI:231601

object_name: Plasma cell myeloma recurrent


subject: CHEBI:231601

object_name: Recurrent Lymphoma


subject: CHEBI:231601

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:231601

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:231601

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:231601

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:231601

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:231601

object_name: uterine corpus cancer


subject: CHEBI:231601

object_name: uterine cancer


subject: CHEBI:231601

object_name: Colorectal cancer recurrent


subject: CHEBI:231601

object_name: Recurrent Liver Carcinoma


subject: CHEBI:231601

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:231601

object_name: Recurrent Skin Carcinoma


subject: CHEBI:231601

object_name: thyroid gland carcinoma


subject: CHEBI:231601

object_name: Melanoma recurrent


subject: CHEBI:231601

object_name: rectal carcinoma


subject: CHEBI:231601

object_name: Recurrent Glioma


subject: CHEBI:231601

object_name: suppressor of tumorigenicity 3


subject: CHEBI:231601

object_name: prostate carcinoma


subject: CHEBI:231601

object_name: malignant epithelial tumor of ovary


subject: CHEBI:231601

object_name: renal carcinoma


subject: CHEBI:231601

object_name: colon carcinoma


subject: CHEBI:231601

object_name: skin carcinoma


subject: CHEBI:231601

object_name: glioma


subject: UNII:SE2KH7T06F

object_name: adult lymphoma


subject: UNII:SE2KH7T06F

object_name: lymphoma


subject: UNII:SE2KH7T06F

object_name: pediatric lymphoma


subject: UNII:SE2KH7T06F

object_name: Plasma cell myeloma recurrent


subject: UNII:SE2KH7T06F

object_name: Recurrent Lymphoma


subject: UNII:SE2KH7T06F

object_name: Recurrent Malignant Solid Neoplasm


subject: UNII:SE2KH7T06F

object_name: Recurrent Head and Neck Carcinoma


subject: UNII:SE2KH7T06F

object_name: uterine cancer


subject: UNII:SE2KH7T06F

object_name: Colorectal cancer recurrent


subject: UNII:SE2KH7T06F

object_name: Recurrent Liver Carcinoma


subject: UNII:SE2KH7T06F

object_name: Recurrent Unspecified Lung Carcinoma


subject: UNII:SE2KH7T06F

object_name: Recurrent Skin Carcinoma


subject: UNII:SE2KH7T06F

object_name: thyroid gland carcinoma


subject: UNII:SE2KH7T06F

object_name: Melanoma recurrent


subject: UNII:SE2KH7T06F

object_name: rectal carcinoma


subject: UNII:SE2KH7T06F

object_name: Recurrent Glioma


subject: UNII:SE2KH7T06F

object_name: suppressor of tumorigenicity 3


subject: UNII:SE2KH7T06F

object_name: prostate carcinoma


subject: UNII:SE2KH7T06F

object_name: malignant epithelial tumor of ovary


subject: UNII:SE2KH7T06F

object_name: renal carcinoma


subject: UNII:SE2KH7T06F

object_name: colon carcinoma


subject: UNII:SE2KH7T06F

object_name: skin carcinoma


subject: UNII:SE2KH7T06F

object_name: glioma


subject: UMLS:C0338204

subject_name: Herceptin

object_name: adult lymphoma


subject: UMLS:C0338204

object_name: lymphoma


subject: UMLS:C0338204

object_name: pediatric lymphoma


subject: UMLS:C0338204

object_name: Plasma cell myeloma refractory


subject: UMLS:C0338204

object_name: Refractory Lymphoma


subject: UMLS:C0338204

object_name: Advanced Lymphoma


subject: UMLS:C0338204

object_name: Plasma cell myeloma recurrent


subject: UMLS:C0338204

object_name: Recurrent Lymphoma


subject: UMLS:C0338204

object_name: Refractory Malignant Solid Neoplasm


subject: UMLS:C0338204

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C0338204

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C0338204

object_name: Recurrent Malignant Solid Neoplasm


subject: UMLS:C0338204

object_name: Recurrent Head and Neck Carcinoma


subject: UMLS:C0338204

object_name: uterine corpus cancer


subject: UMLS:C0338204

object_name: uterine cancer


subject: UMLS:C0338204

object_name: Colorectal cancer recurrent


subject: UMLS:C0338204

object_name: Recurrent Liver Carcinoma


subject: UMLS:C0338204

object_name: Recurrent Unspecified Lung Carcinoma


subject: UMLS:C0338204

object_name: Recurrent Skin Carcinoma


subject: UMLS:C0338204

object_name: thyroid gland carcinoma


subject: UMLS:C0338204

object_name: Melanoma recurrent


subject: UMLS:C0338204

object_name: rectal carcinoma


subject: UMLS:C0338204

object_name: Recurrent Glioma


subject: UMLS:C0338204

object_name: suppressor of tumorigenicity 3


subject: UMLS:C0338204

object_name: prostate carcinoma


subject: UMLS:C0338204

object_name: malignant epithelial tumor of ovary


subject: UMLS:C0338204

object_name: renal carcinoma


subject: UMLS:C0338204

object_name: colon carcinoma


subject: UMLS:C0338204

object_name: skin carcinoma


subject: UMLS:C0338204

object_name: glioma


subject: UMLS:C2826229

object_name: plasma cell myeloma


subject: UMLS:C2826229

object_name: adult lymphoma


subject: UMLS:C2826229

object_name: lymphoma


subject: UMLS:C2826229

object_name: pediatric lymphoma


subject: UMLS:C2826229

object_name: Plasma cell myeloma recurrent


subject: UMLS:C2826229

object_name: Recurrent Lymphoma


subject: UMLS:C2826229

object_name: Recurrent Malignant Solid Neoplasm


subject: UMLS:C2826229

object_name: Pancreatic carcinoma recurrent


subject: UMLS:C2826229

object_name: Recurrent Rectal Cancer


subject: UMLS:C2826229

object_name: Recurrent Head and Neck Carcinoma


subject: UMLS:C2826229

object_name: Recurrent Thyroid Carcinoma


subject: UMLS:C2826229

object_name: Neck Carcinoma


subject: UMLS:C2826229

object_name: uterine corpus cancer


subject: UMLS:C2826229

object_name: Prostate cancer recurrent


subject: UMLS:C2826229

object_name: endometrial carcinoma


subject: UMLS:C2826229

object_name: uterine cancer


subject: UMLS:C2826229

object_name: Colorectal cancer recurrent


subject: UMLS:C2826229

object_name: Recurrent ovarian cancer


subject: UMLS:C2826229

object_name: Oesophageal carcinoma recurrent


subject: UMLS:C2826229

object_name: Cervix carcinoma recurrent


subject: UMLS:C2826229

object_name: exocrine pancreatic carcinoma


subject: UMLS:C2826229

object_name: recurrent gastric cancer


subject: UMLS:C2826229

object_name: Bladder cancer recurrent


subject: UMLS:C2826229

object_name: Recurrent Liver Carcinoma


subject: UMLS:C2826229

object_name: Colon cancer recurrent


subject: UMLS:C2826229

object_name: Recurrent Unspecified Lung Carcinoma


subject: UMLS:C2826229

object_name: Recurrent Skin Carcinoma


subject: UMLS:C2826229

object_name: thyroid gland carcinoma


subject: UMLS:C2826229

object_name: Melanoma recurrent


subject: UMLS:C2826229

object_name: rectal carcinoma


subject: UMLS:C2826229

object_name: rectum adenocarcinoma


subject: UMLS:C2826229

object_name: Recurrent Glioma


subject: UMLS:C2826229

object_name: suppressor of tumorigenicity 3


subject: UMLS:C2826229

object_name: cervical carcinoma


subject: UMLS:C2826229

object_name: prostate carcinoma


subject: UMLS:C2826229

object_name: ovarian cancer


subject: UMLS:C2826229

object_name: ovarian carcinoma


subject: UMLS:C2826229

object_name: malignant epithelial tumor of ovary


subject: UMLS:C2826229

object_name: renal carcinoma


subject: UMLS:C2826229

object_name: renal cell carcinoma


subject: UMLS:C2826229

object_name: liver carcinoma


subject: UMLS:C2826229

object_name: colon carcinoma


subject: UMLS:C2826229

object_name: skin carcinoma


subject: UMLS:C2826229

object_name: melanoma


subject: UMLS:C2826229

object_name: glioma


subject: UMLS:C2826229

object_name: malignant glioma


subject: PUBCHEM.COMPOUND:58641927

subject_name: Ulixertinib

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:58641927

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:58641927

object_name: lymphoma


subject: PUBCHEM.COMPOUND:58641927

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:58641927

object_name: Plasma cell myeloma recurrent


subject: PUBCHEM.COMPOUND:58641927

object_name: Recurrent Lymphoma


subject: PUBCHEM.COMPOUND:58641927

object_name: hematopoietic and lymphoid cell neoplasm


subject: PUBCHEM.COMPOUND:58641927

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: PUBCHEM.COMPOUND:58641927

object_name: Pancreatic carcinoma recurrent


subject: PUBCHEM.COMPOUND:58641927

object_name: Recurrent Rectal Cancer


subject: PUBCHEM.COMPOUND:58641927

object_name: Recurrent Head and Neck Carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: Recurrent Thyroid Carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: Neck Carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: uterine corpus cancer


subject: PUBCHEM.COMPOUND:58641927

object_name: Prostate cancer recurrent


subject: PUBCHEM.COMPOUND:58641927

object_name: endometrial carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: uterine cancer


subject: PUBCHEM.COMPOUND:58641927

object_name: Breast cancer recurrent


subject: PUBCHEM.COMPOUND:58641927

object_name: Colorectal cancer recurrent


subject: PUBCHEM.COMPOUND:58641927

object_name: Recurrent ovarian cancer


subject: PUBCHEM.COMPOUND:58641927

object_name: Oesophageal carcinoma recurrent


subject: PUBCHEM.COMPOUND:58641927

object_name: Cervix carcinoma recurrent


subject: PUBCHEM.COMPOUND:58641927

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: recurrent gastric cancer


subject: PUBCHEM.COMPOUND:58641927

object_name: Bladder cancer recurrent


subject: PUBCHEM.COMPOUND:58641927

object_name: Recurrent Liver Carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: Colon cancer recurrent


subject: PUBCHEM.COMPOUND:58641927

object_name: Recurrent Unspecified Lung Carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: Recurrent Skin Carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: thyroid gland carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: Melanoma recurrent


subject: PUBCHEM.COMPOUND:58641927

object_name: carcinoma of esophagus


subject: PUBCHEM.COMPOUND:58641927

object_name: rectal carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: rectum adenocarcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: suppressor of tumorigenicity 3


subject: PUBCHEM.COMPOUND:58641927

object_name: cervical carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: Stomach cancer


subject: PUBCHEM.COMPOUND:58641927

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:58641927

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: malignant epithelial tumor of ovary


subject: PUBCHEM.COMPOUND:58641927

object_name: urinary bladder carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: renal carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: renal cell carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: colon carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: skin carcinoma


subject: PUBCHEM.COMPOUND:58641927

object_name: melanoma


subject: PUBCHEM.COMPOUND:58641927

object_name: glioma


subject: PUBCHEM.COMPOUND:58641927

object_name: malignant glioma


subject: UMLS:C4287812

subject_name: ulixertinib

object_name: plasma cell myeloma


subject: UMLS:C4287812

object_name: adult lymphoma


subject: UMLS:C4287812

object_name: lymphoma


subject: UMLS:C4287812

object_name: pediatric lymphoma


subject: UMLS:C4287812

object_name: Plasma cell myeloma recurrent


subject: UMLS:C4287812

object_name: Recurrent Lymphoma


subject: UMLS:C4287812

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C4287812

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C4287812

object_name: Pancreatic carcinoma recurrent


subject: UMLS:C4287812

object_name: Recurrent Rectal Cancer


subject: UMLS:C4287812

object_name: Recurrent Head and Neck Carcinoma


subject: UMLS:C4287812

object_name: Recurrent Thyroid Carcinoma


subject: UMLS:C4287812

object_name: Neck Carcinoma


subject: UMLS:C4287812

object_name: uterine corpus cancer


subject: UMLS:C4287812

object_name: Prostate cancer recurrent


subject: UMLS:C4287812

object_name: endometrial carcinoma


subject: UMLS:C4287812

object_name: uterine cancer


subject: UMLS:C4287812

object_name: Breast cancer recurrent


subject: UMLS:C4287812

object_name: Colorectal cancer recurrent


subject: UMLS:C4287812

object_name: Recurrent ovarian cancer


subject: UMLS:C4287812

object_name: Oesophageal carcinoma recurrent


subject: UMLS:C4287812

object_name: Cervix carcinoma recurrent


subject: UMLS:C4287812

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4287812

object_name: recurrent gastric cancer


subject: UMLS:C4287812

object_name: Bladder cancer recurrent


subject: UMLS:C4287812

object_name: Recurrent Liver Carcinoma


subject: UMLS:C4287812

object_name: Colon cancer recurrent


subject: UMLS:C4287812

object_name: Recurrent Unspecified Lung Carcinoma


subject: UMLS:C4287812

object_name: Recurrent Skin Carcinoma


subject: UMLS:C4287812

object_name: thyroid gland carcinoma


subject: UMLS:C4287812

object_name: breast carcinoma


subject: UMLS:C4287812

object_name: colorectal carcinoma


subject: UMLS:C4287812

object_name: Melanoma recurrent


subject: UMLS:C4287812

object_name: carcinoma of esophagus


subject: UMLS:C4287812

object_name: rectal carcinoma


subject: UMLS:C4287812

object_name: rectum adenocarcinoma


subject: UMLS:C4287812

object_name: suppressor of tumorigenicity 3


subject: UMLS:C4287812

object_name: cervical carcinoma


subject: UMLS:C4287812

object_name: prostate carcinoma


subject: UMLS:C4287812

object_name: Stomach cancer


subject: UMLS:C4287812

object_name: ovarian cancer


subject: UMLS:C4287812

object_name: ovarian carcinoma


subject: UMLS:C4287812

object_name: malignant epithelial tumor of ovary


subject: UMLS:C4287812

object_name: urinary bladder carcinoma


subject: UMLS:C4287812

object_name: renal carcinoma


subject: UMLS:C4287812

object_name: renal cell carcinoma


subject: UMLS:C4287812

object_name: liver carcinoma


subject: UMLS:C4287812

object_name: colon carcinoma


subject: UMLS:C4287812

object_name: lung carcinoma


subject: UMLS:C4287812

object_name: skin carcinoma


subject: UMLS:C4287812

object_name: melanoma


subject: UMLS:C4287812

object_name: glioma


subject: UMLS:C4287812

object_name: malignant glioma


subject: CHEBI:66903

subject_name: Vismodegib

object_name: plasma cell myeloma


subject: CHEBI:66903

object_name: adult lymphoma


subject: CHEBI:66903

object_name: lymphoma


subject: CHEBI:66903

object_name: pediatric lymphoma


subject: CHEBI:66903

object_name: Refractory Lymphoma


subject: CHEBI:66903

object_name: Advanced Lymphoma


subject: CHEBI:66903

object_name: Plasma cell myeloma recurrent


subject: CHEBI:66903

object_name: Recurrent Lymphoma


subject: CHEBI:66903

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:66903

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:66903

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:66903

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:66903

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:66903

object_name: Recurrent Rectal Cancer


subject: CHEBI:66903

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:66903

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:66903

object_name: Neck Carcinoma


subject: CHEBI:66903

object_name: uterine corpus cancer


subject: CHEBI:66903

object_name: Prostate cancer recurrent


subject: CHEBI:66903

object_name: endometrial carcinoma


subject: CHEBI:66903

object_name: uterine cancer


subject: CHEBI:66903

object_name: Colorectal cancer recurrent


subject: CHEBI:66903

object_name: Recurrent ovarian cancer


subject: CHEBI:66903

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:66903

object_name: Cervix carcinoma recurrent


subject: CHEBI:66903

object_name: exocrine pancreatic carcinoma


subject: CHEBI:66903

object_name: Bladder cancer recurrent


subject: CHEBI:66903

object_name: Recurrent Liver Carcinoma


subject: CHEBI:66903

object_name: Colon cancer recurrent


subject: CHEBI:66903

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:66903

object_name: thyroid gland carcinoma


subject: CHEBI:66903

object_name: colorectal carcinoma


subject: CHEBI:66903

object_name: Melanoma recurrent


subject: CHEBI:66903

object_name: carcinoma of esophagus


subject: CHEBI:66903

object_name: rectal carcinoma


subject: CHEBI:66903

object_name: rectum adenocarcinoma


subject: CHEBI:66903

object_name: Recurrent Glioma


subject: CHEBI:66903

object_name: suppressor of tumorigenicity 3


subject: CHEBI:66903

object_name: cervical carcinoma


subject: CHEBI:66903

object_name: Stomach cancer


subject: CHEBI:66903

object_name: malignant epithelial tumor of ovary


subject: CHEBI:66903

object_name: renal carcinoma


subject: CHEBI:66903

object_name: renal cell carcinoma


subject: CHEBI:66903

object_name: liver carcinoma


subject: CHEBI:66903

object_name: colon carcinoma


subject: CHEBI:66903

object_name: lung carcinoma


subject: CHEBI:66903

object_name: skin carcinoma


subject: CHEBI:66903

object_name: melanoma


subject: CHEBI:66903

object_name: glioma


subject: CHEBI:66903

object_name: malignant glioma


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: mucosal melanoma


subject: UMLS:C2979805

subject_name: Corifact

object_name: congenital factor XIII deficiency


subject: UMLS:C2979805

object_name: factor XIII deficiency


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Complication of transplant


subject: CHEBI:61057

object_name: Complication of transplanted organ, NOS


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:4903

subject_name: Ethinylestradiol

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:521267

subject_name: (R)-Carvotanacetone

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:521267


subject: CHEBI:50742

subject_name: cyproterone


subject: CHEBI:50742


subject: CHEBI:74947

subject_name: Thalidomide

object_name: beta-thalassemia HBB/LCRB


subject: UMLS:C0082559

subject_name: Feiba

object_name: Hemorrhage


subject: UMLS:C0082559

object_name: Surgical procedure finding


subject: CHEBI:50859

subject_name: Bexarotene

object_name: thyroid tumor


subject: CHEBI:50859

object_name: thyroid gland carcinoma


subject: CHEBI:50859

object_name: thyroid cancer


subject: UNII:8Z13S29R5A

subject_name: lumiliximab

object_name: leukemia


subject: UNII:8Z13S29R5A

object_name: childhood leukemia


subject: UNII:8Z13S29R5A

object_name: adult lymphoma


subject: UNII:8Z13S29R5A

object_name: lymphoma


subject: UNII:8Z13S29R5A

object_name: pediatric lymphoma


subject: UMLS:C1327944


subject: UMLS:C1327944


subject: UMLS:C1327944


subject: UMLS:C1327944


subject: UMLS:C1327944


subject: UMLS:C1705207

subject_name: Endostar

object_name: Non-small cell lung cancer recurrent


subject: UMLS:C2975326

object_name: asthma


subject: CHEBI:141439

subject_name: Ile-Asp

object_name: dengue disease


subject: UniProtKB:P20067

subject_name: ID1_MOUSE DNA-binding protein inhibitor ID-1 (sprot)


subject: PR:000000039

subject_name: DNA-binding protein inhibitor ID-1


subject: CHEBI:33330

subject_name: scandium atom


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: CHEBI:16302

object_name: bronchopulmonary dysplasia


subject: CHEBI:16302

object_name: Bronchopulmonary Dysplasia, AE


subject: CHEBI:16302

object_name: fetal growth restriction


subject: CHEBI:16302

object_name: congenital alveolar dysplasia


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UNII:81G40H8B0T


subject: UNII:81G40H8B0T


subject: UNII:81G40H8B0T


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: UMLS:C3714656


subject: UMLS:C3714656


subject: UMLS:C3714656


subject: CHEBI:12777

subject_name: Vitamin A


subject: CHEBI:12777


subject: CHEBI:12777


subject: CHEBI:12777


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: UMLS:C2825076


subject: UMLS:C2825076


subject: UMLS:C2825076


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: otitis media


subject: UNII:6GNT3Y5LMF

object_name: infectious otitis media


subject: UNII:6GNT3Y5LMF

object_name: Otitis Media, CTCAE


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: CHEBI:63598


subject: UMLS:C3896757

subject_name: TGFBR1 Inhibitor TEW-7197

object_name: Myelodysplasia


subject: CHEBI:28834

object_name: adult liposarcoma


subject: CHEBI:28834

object_name: liposarcoma


subject: CHEBI:28834

object_name: pediatric liposarcoma


subject: CHEBI:28834

object_name: leiomyosarcoma


subject: CHEBI:28834

object_name: Childhood Leiomyosarcoma


subject: CHEBI:28834

object_name: Adult Leiomyosarcoma


subject: UMLS:C4305918


subject: UMLS:C4305918


subject: UMLS:C4305918


subject: UMLS:C4305918


subject: UMLS:C4305918


subject: UMLS:C4305918


subject: GTOPDB:2509

subject_name: NO

object_name: Hypoxic respiratory failure


subject: GTOPDB:2509

object_name: pulmonary hypertension


subject: GTOPDB:2509

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:33396

subject_name: nobelium


subject: CHEBI:33396


subject: CHEBI:33396


subject: CHEBI:16480

subject_name: Nitric Oxide


subject: CHEMBL.COMPOUND:CHEMBL5095278

subject_name: LORIGERLIMAB

object_name: colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: colorectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: CHEMBL.COMPOUND:CHEMBL5314359

subject_name: ERTAPENEM SODIUM

object_name: Infection


subject: CHEMBL.COMPOUND:CHEMBL5314359

object_name: infectious disease


subject: CHEMBL.COMPOUND:CHEMBL5314359

object_name: Adverse Event Associated with Infection


subject: CHEMBL.COMPOUND:CHEMBL5314359

object_name: urinary tract infection


subject: CHEMBL.COMPOUND:CHEMBL5314359

object_name: bacterial urinary tract infection


subject: CHEMBL.COMPOUND:CHEMBL5314359

object_name: Urinary Tract Infection, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL5314359

object_name: pneumonia


subject: CHEMBL.COMPOUND:CHEMBL5314359

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:404903

subject_name: Ertapenem


subject: CHEBI:404903


subject: CHEBI:404903


subject: CHEBI:404903


subject: CHEBI:404903


subject: CHEBI:404903


subject: CHEBI:404903


subject: UMLS:C2830049

object_name: Oral Mucositis


subject: UMLS:C2830049

object_name: stomatitis


subject: UMLS:C2830049

object_name: oral mucositis


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: General anesthetic drug adverse reaction


subject: CHEBI:28427

subject_name: arabinoxylan

object_name: Weight loss


subject: CHEBI:28427

object_name: Weight Loss, CTCAE


subject: CHEBI:28427

object_name: Overweight and obesity


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: pulmonary hypertension


subject: CHEBI:85078

object_name: Pulmonary Hypertension, CTCAE


subject: UMLS:C5433403

subject_name: Forxiga


subject: UMLS:C5433403


subject: CHEBI:7465

subject_name: Naltrexone

object_name: New daily persistent headache (NDPH)


subject: UMLS:C1382110

subject_name: powder physical state


subject: UNII:X8UHF7SX0R

subject_name: Casimersen

object_name: Duchenne muscular dystrophy


subject: UMLS:C5222068

subject_name: Vyondys 53


subject: UMLS:C5420828

subject_name: Gallium Ga 68-NOTA-MAL-Cys39-exendin-4

object_name: insulinoma


subject: CHEBI:36121

subject_name: flavylium

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C0042971

subject_name: von Willebrand factor

object_name: von Willebrand disease (hereditary or acquired)


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Endometrial carcinosarcoma


subject: UNII:28X28X9OKV

object_name: Recurrent Endometrial Cancer


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX

object_name: endometrial cancer


subject: UNII:QEN1X95CIX

object_name: uterine corpus cancer


subject: UNII:QEN1X95CIX

object_name: endometrial carcinoma


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:6532

subject_name: Loperamide

object_name: colorectal cancer


subject: CHEBI:6532

object_name: colorectal carcinoma


subject: CHEBI:6532

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:6532

object_name: Childhood Solid Neoplasm


subject: CHEBI:6532

object_name: Adult Solid Neoplasm


subject: CHEBI:6532

object_name: Solid Neoplasm


subject: UNII:X4Z7U6JL1C

subject_name: POZIOTINIB HYDROCHLORIDE


subject: UNII:X4Z7U6JL1C


subject: UNII:X4Z7U6JL1C


subject: UNII:X4Z7U6JL1C

object_name: Childhood Breast Carcinoma


subject: UNII:X4Z7U6JL1C

object_name: breast carcinoma


subject: UNII:X4Z7U6JL1C

object_name: breast cancer


subject: UNII:X4Z7U6JL1C


subject: UNII:X4Z7U6JL1C


subject: UNII:X4Z7U6JL1C


subject: UMLS:C5447492

subject_name: Poziotinib Hydrochloride


subject: UMLS:C5447492


subject: UMLS:C5447492


subject: UMLS:C5447492


subject: UMLS:C5447492


subject: UMLS:C5447492


subject: UMLS:C5447492


subject: UMLS:C5447492


subject: UMLS:C5447492


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Osteoporotic Fractures


subject: UMLS:C1530450

subject_name: AMG 162


subject: CHEBI:182913

subject_name: Dexpramipexole

object_name: cocaine dependence


subject: CHEBI:182913

object_name: cocaine abuse


subject: CHEBI:182913

object_name: Harmful pattern of substance use


subject: CHEBI:182913

object_name: substance abuse


subject: CHEBI:8356

subject_name: Pramipexole


subject: CHEBI:8356


subject: CHEBI:8356


subject: CHEBI:8356


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: type 1 diabetes mellitus


subject: PUBCHEM.COMPOUND:92043599

object_name: hypoglycemia


subject: PUBCHEM.COMPOUND:92043599

object_name: Blood glucose below reference range (finding)


subject: PUBCHEM.COMPOUND:92043599

object_name: Hypoglycemia, CTCAE


subject: HMDB:HMDB0000668

subject_name: Hematoporphyrin IX

object_name: Protein Deficiency


subject: CHEBI:147379

subject_name: His-Pro


subject: CHEBI:24526

subject_name: heptyl group


subject: CHEBI:32184

subject_name: Tazarotene

object_name: interstitial lung disease 1


subject: CHEBI:32184

object_name: interstitial lung disease 2


subject: CHEBI:32184

object_name: pulmonary fibrosis


subject: CHEBI:32184

object_name: idiopathic interstitial pneumonia


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: chronic obstructive pulmonary disease


subject: UMLS:C1527024

subject_name: Birch antigen

object_name: Atopic rhinitis


subject: UMLS:C1527024

object_name: Allergic Rhinitis, CTCAE


subject: UMLS:C1366021

subject_name: Birch preparation


subject: UMLS:C1366021


subject: PUBCHEM.COMPOUND:9886134

subject_name: Branched chain amino acids

object_name: Increased metabolic requirement


subject: UMLS:C0002521

subject_name: Amino Acids, Branched-Chain


subject: UMLS:C0002525

subject_name: Amino Acids, Essential


subject: CHEBI:48843

subject_name: sodium selenite

object_name: heart disorder


subject: CHEBI:2965

object_name: coronary atherosclerosis


subject: UMLS:C0379142


subject: UMLS:C1268858

subject_name: Magnesium supplement

object_name: Menopause present (finding)


subject: UMLS:C1268858

object_name: Menopause


subject: UMLS:C1268858

object_name: bone disorder


subject: UMLS:C1268859

subject_name: Zinc supplement


subject: UMLS:C1268859


subject: UMLS:C1268859


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: HIV infection


subject: CHEBI:17460

subject_name: Thioctamide

object_name: peripheral nervous system disorder


subject: CHEBI:17460

object_name: neuropathy


subject: CHEBI:17460


subject: CHEBI:16494

subject_name: thioctic acid


subject: UNII:37NT056AT4

subject_name: Remetinostat

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:3238

subject_name: Butenafine

object_name: tinea pedis


subject: PUBCHEM.COMPOUND:135436482

subject_name: Calcium folinate

object_name: toxoplasmosis


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:8673

subject_name: Pyrimethamine


subject: UniProtKB:Q9X034

subject_name: MTAD_THEMA 5-methylthioadenosine/S-adenosylhomocysteine deaminase (sprot)

object_name: dental pulp necrosis


subject: CHEBI:27306

subject_name: vitamin B6

object_name: pyridoxine deficiency anemia


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: suppressor of tumorigenicity 3


subject: GTOPDB:9758

object_name: adverse effect


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UNII:K27MHH614O

subject_name: mitoquinol

object_name: asthma


subject: UNII:K27MHH614O

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:K27MHH614O

object_name: obesity


subject: UNII:K27MHH614O

object_name: Obesity, CTCAE


subject: PR:000001151

subject_name: Toll-like receptor 1

object_name: glioblastoma


subject: PR:000001151

object_name: Brain Stem Glioblastoma


subject: PR:000001151

object_name: glioma susceptibility 1


subject: RXCUI:404930

subject_name: Ciprodex

object_name: otitis media


subject: RXCUI:404930

object_name: infectious otitis media


subject: RXCUI:404930

object_name: Otitis Media, CTCAE


subject: RXCUI:404930

object_name: discharging ear


subject: CHEBI:8869

subject_name: Risedronic acid

object_name: Menopause present (finding)


subject: CHEBI:8869

object_name: Menopause


subject: MESH:D009822

subject_name: Oils, Volatile

object_name: periapical periodontitis


subject: MESH:D009822

object_name: dental pulp necrosis


subject: CHEBI:83630

subject_name: essential oil


subject: CHEBI:83630


subject: CHEBI:3374

subject_name: Capsaicin

object_name: psoriasis


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:39548

object_name: clear cell renal carcinoma


subject: CHEBI:39548

object_name: renal cell adenocarcinoma


subject: CHEBI:39548

object_name: renal cell carcinoma


subject: CHEBI:39548

object_name: renal carcinoma


subject: CHEBI:39548

object_name: kidney neoplasm


subject: CHEBI:39548

object_name: kidney cancer


subject: UMLS:C0392938

subject_name: zoledronate


subject: UMLS:C0392938


subject: UMLS:C0392938


subject: UMLS:C0392938


subject: UMLS:C0392938


subject: UMLS:C0392938


subject: UMLS:C0392938


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:3757

subject_name: Clonidine

object_name: cocaine abuse


subject: CHEBI:3757

object_name: heroin abuse


subject: CHEMBL.COMPOUND:CHEMBL1187846

subject_name: SCOPOLAMINE

object_name: social phobia


subject: KEGG.COMPOUND:C01851

subject_name: Scopolamine


subject: CHEBI:91541


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: Recurrent Endometrial Cancer


subject: PUBCHEM.COMPOUND:3080587

object_name: Endometrial cancer stage II


subject: PUBCHEM.COMPOUND:3080587

object_name: Stage IA Uterine Corpus Cancer AJCC v7


subject: PUBCHEM.COMPOUND:3080587

object_name: Stage IB Uterine Corpus Cancer AJCC v7


subject: PUBCHEM.COMPOUND:3080587

object_name: Stage IVA Uterine Corpus Cancer AJCC v7


subject: PUBCHEM.COMPOUND:3080587

object_name: Stage IVB Uterine Corpus Cancer AJCC v7


subject: PUBCHEM.COMPOUND:3080587

object_name: Stage IIIC Uterine Corpus Cancer AJCC v7


subject: PUBCHEM.COMPOUND:3080587

object_name: Stage IIIA Uterine Corpus Cancer AJCC v7


subject: PUBCHEM.COMPOUND:3080587

object_name: Stage IIIB Uterine Corpus Cancer AJCC v7


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: End stage renal failure with renal transplant


subject: UNII:5G1WE425BI

subject_name: Rilzabrutinib

object_name: autoimmune thrombocytopenia


subject: UNII:5G1WE425BI

object_name: thrombocytopenia due to immune destruction


subject: UNII:5G1WE425BI

object_name: autoimmune thrombocytopenic purpura


subject: UNII:NWN58M4F5T

subject_name: RILZABRUTINIB


subject: UNII:NWN58M4F5T


subject: UNII:NWN58M4F5T


subject: CHEBI:28177

subject_name: Theophylline

object_name: Traumatic anosmia


subject: PUBCHEM.COMPOUND:169422740


subject: CHEBI:63450

subject_name: Masitinib

object_name: asthma


subject: CHEBI:71272

subject_name: Saxagliptin

object_name: Catecholamine hypersecretion


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: psoriasis vulgaris


subject: UMLS:C5666876

subject_name: BRAF V600E Inhibitor HLX208

object_name: metastatic colorectal cancer


subject: UNII:AQK7UBA1LS

subject_name: Luspatercept

object_name: ovarian granulosa cell tumor


subject: UNII:AQK7UBA1LS

object_name: maligant granulosa cell tumor of ovary


subject: UMLS:C3641690


subject: UMLS:C3641690


subject: CHEBI:231614

subject_name: Nivolumab

object_name: primary mediastinal large B-cell lymphoma


subject: UMLS:C2346820


subject: CHEBI:95165

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:95165

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:95165

object_name: childhood acute myeloid leukemia with maturation


subject: CHEBI:95165

object_name: Childhood Acute Promyelocytic Leukemia


subject: CHEBI:95165

object_name: Childhood Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: UMLS:C3274621

object_name: Hepatic impairment


subject: PUBCHEM.COMPOUND:9995208

subject_name: Estetrol

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:9995208

object_name: prostate neoplasm


subject: UMLS:C2932519

subject_name: ZuraPrep

object_name: Surgical Wound Infection


subject: GTOPDB:12652

subject_name: magrolimab

object_name: Hodgkin Disease


subject: GTOPDB:12652

object_name: Adult Hodgkin Lymphoma


subject: GTOPDB:12652

object_name: Childhood Hodgkin Lymphoma


subject: GTOPDB:12652

object_name: Classical Hodgkin lymphoma refractory


subject: GTOPDB:12652

object_name: Relapsing classical Hodgkin lymphoma


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C2981808

object_name: melanoma


subject: UMLS:C2981808

object_name: prostate adenocarcinoma


subject: CHEBI:125354

subject_name: Plerixafor

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:125354

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:125354

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:125354

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:125354

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:125354

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:125354

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UMLS:C4547387

object_name: obstructive sleep apnea syndrome


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: Post-Operative Pain


subject: CHEMBL.COMPOUND:CHEMBL2109506

object_name: Childhood Breast Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109506

object_name: breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109506

object_name: breast cancer


subject: UMLS:C0879578


subject: UMLS:C0879578


subject: UMLS:C0879578


subject: CHEBI:71219

subject_name: Pazopanib

object_name: breast neoplasm


subject: UMLS:C1327963


subject: PUBCHEM.COMPOUND:134823896

subject_name: SERDEXMETHYLPHENIDATE

object_name: Adult attention deficit hyperactivity disorder


subject: CHEBI:51860

subject_name: Dexmethylphenidate


subject: CHEBI:40303

subject_name: Lovastatin

object_name: intermittent vascular claudication


subject: CHEBI:40303

object_name: peripheral vascular disease


subject: CHEBI:50733

subject_name: nutraceutical

object_name: mild neurocognitive disorder


subject: CHEBI:50733

object_name: mild cognitive impairment


subject: UMLS:C2752138

subject_name: aloe vera homeopathic preparation


subject: UMLS:C2752138


subject: DRUGBANK:DB13906

subject_name: Aloe vera leaf


subject: DRUGBANK:DB13906


subject: UMLS:C0995182

subject_name: Aloe vera preparation


subject: UMLS:C0995182


subject: CHEBI:79068

subject_name: Crocin


subject: CHEBI:79068


subject: UMLS:C3696061

subject_name: saffron extract


subject: UMLS:C3696061


subject: UMLS:C0162753

subject_name: saffron stain


subject: UMLS:C0162753


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Ovarian failure


subject: UMLS:C0445115

object_name: Perimenopausal disorder


subject: UMLS:C0445115

object_name: endocrine system disorder


subject: CHEBI:33355

subject_name: bohrium atom


subject: CHEBI:33355


subject: CHEBI:33355


subject: CHEBI:33349

subject_name: dubnium atom


subject: CHEBI:33349


subject: CHEBI:33349


subject: CHEBI:73426

subject_name: Asn-Ser


subject: CHEBI:73426


subject: CHEBI:73426


subject: PR:000008117

subject_name: guanine nucleotide-binding protein-like 3


subject: PR:000008117


subject: PR:000008117


subject: CHEBI:7514

subject_name: Neostigmine

object_name: Respiratory conditions due to other external agents


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Stroke (heart beat)


subject: CHEBI:36791

object_name: Stroke, CTCAE


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: UMLS:C1527137

subject_name: Recombinant melatonin


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:17688

subject_name: Nicotine

object_name: Tobacco user


subject: CHEBI:17688

object_name: Tobacco use history


subject: CHEBI:17688

object_name: Encounter due to tobacco use


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: hypoalphalipoproteinemia


subject: PUBCHEM.COMPOUND:5470

subject_name: tibolone


subject: UMLS:C5706443

subject_name: CDK2 Inhibitor BLU-222

object_name: ovarian cancer


subject: UMLS:C5706443

object_name: ovarian neoplasm


subject: UMLS:C5706443

object_name: ovarian carcinoma


subject: UMLS:C5706443

object_name: Stomach cancer


subject: UMLS:C5706443

object_name: gastric cancer


subject: UMLS:C5706443

object_name: Her2-receptor negative breast cancer


subject: UMLS:C5706443

object_name: endometrial cancer


subject: UMLS:C5706443

object_name: uterine corpus cancer


subject: UMLS:C5706443

object_name: endometrial carcinoma


subject: UMLS:C5706443

object_name: CCNE1 Gene Amplification


subject: UMLS:C5706443

object_name: esophageal adenocarcinoma


subject: UMLS:C5706443

object_name: carcinosarcoma


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:91951


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: CHEBI:230905

subject_name: Ribociclib


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: UNII:P7186074QC

subject_name: Rozanolixizumab

object_name: myasthenia gravis


subject: UNII:P7186074QC

object_name: Myasthenia Gravis, CTCAE


subject: UMLS:C3890420

subject_name: Realgar-Indigo naturalis Formulation

object_name: acute promyelocytic leukemia


subject: RXCUI:404930

subject_name: Ciprodex

object_name: beach ear


subject: CHEBI:230540

object_name: childhood neoplasm


subject: CHEBI:230540

object_name: neoplastic syndrome


subject: CHEBI:230540

object_name: cancer or benign tumor


subject: CHEBI:230540

object_name: neoplasm


subject: UMLS:C2983789


subject: UMLS:C2983789


subject: UMLS:C2983789


subject: UMLS:C2983789


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: Antibody-mediated rejection


subject: CHEBI:167473

subject_name: hexopyranose

object_name: steroid-resistant nephrotic syndrome


subject: CHEBI:167473

object_name: focal segmental glomerulosclerosis


subject: CHEBI:27667

subject_name: b-D-GALACTOSE


subject: CHEBI:27667


subject: CHEBI:28061

subject_name: galactose


subject: CHEBI:12936

subject_name: D-galactose


subject: CHEBI:12936


subject: UNII:5B38CV1212

object_name: type 2 diabetes mellitus


subject: UMLS:C3886550


subject: CHEBI:15551

subject_name: Dinoprostone

object_name: IUD insertion complication


subject: UNII:6897GXD6OE

object_name: Anaemia postoperative


subject: UNII:6897GXD6OE

object_name: osteoarthritis, knee


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: heart failure


subject: CHEBI:63611

object_name: Heart Failure, CTCAE


subject: CHEBI:63611

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:63611

object_name: pulmonary hypertension


subject: CHEBI:63611

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:63611

object_name: pulmonary arterial hypertension


subject: CHEBI:63611

object_name: cardiovascular disorder


subject: RXCUI:8375

subject_name: placebo Oral Tablet


subject: RXCUI:8375


subject: RXCUI:8375


subject: RXCUI:8375


subject: RXCUI:8375


subject: RXCUI:8375


subject: RXCUI:8375


subject: UNII:1P05PW62F3

subject_name: CONBERCEPT

object_name: diabetic macular edema


subject: UNII:NY0COC51FI

subject_name: Tradipitant

object_name: Pruritus, CTCAE


subject: UNII:NY0COC51FI

object_name: Pruritus


subject: CHEBI:31401

subject_name: Cilostazol

object_name: Parkinson disease


subject: CHEBI:3745

subject_name: clindamycin

object_name: periodontitis


subject: CHEBI:3745

object_name: diabetes mellitus


subject: CHEBI:3745

object_name: Periodontal Pocket


subject: PUBCHEM.COMPOUND:9954530

subject_name: Bidil


subject: PUBCHEM.COMPOUND:9954530

object_name: congestive heart failure


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: pulmonary sarcoidosis


subject: CHEBI:85164


subject: MESH:C000710692

object_name: mild neurocognitive disorder


subject: MESH:C000710692

object_name: mild cognitive impairment


subject: CHEBI:7465

subject_name: Naltrexone

object_name: post-traumatic stress disorder


subject: UMLS:C0939699

subject_name: Glucophage XR


subject: PUBCHEM.COMPOUND:44573417

subject_name: METFORMIN XR


subject: PUBCHEM.COMPOUND:3043660


subject: UMLS:C4726752

subject_name: Sevuparin Sodium

object_name: Plasmodium falciparum malaria


subject: CHEBI:95346

subject_name: Atovaquone


subject: PUBCHEM.COMPOUND:135402036

object_name: Weight Gain


subject: PUBCHEM.COMPOUND:135402036

object_name: Weight Gain, CTCAE


subject: CHEBI:17202

subject_name: Inosinic Acid


subject: CHEBI:17202


subject: CHEBI:58053


subject: CHEBI:58053


subject: CHEBI:190509

subject_name: Imipenem


subject: CHEBI:190509


subject: CHEBI:75551


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Childhood L2 Acute Lymphoblastic Leukemia


subject: CHEBI:9168

object_name: Childhood L1 Acute Lymphoblastic Leukemia


subject: CHEBI:9168

object_name: B-cell childhood acute lymphoblastic leukemia


subject: CHEBI:9168

object_name: T-cell childhood acute lymphocytic leukemia


subject: UNII:2ZRZ4TSW3F

subject_name: Thymectacin

object_name: colorectal cancer


subject: UNII:2ZRZ4TSW3F

object_name: colorectal carcinoma


subject: UNII:2ZRZ4TSW3F

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C2830008

subject_name: Brivudine phosphoramidate


subject: UMLS:C2830008


subject: UMLS:C2830008


subject: CHEMBL.COMPOUND:CHEMBL5095381

subject_name: RECATICIMAB

object_name: non-small cell lung carcinoma


subject: UMLS:C5446789

subject_name: Recaticimab


subject: CHEBI:140478

subject_name: Pavinetant

object_name: schizophrenia


subject: UMLS:C2975298


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: radiation proctitis


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:50838

subject_name: Drospirenone

object_name: endometriosis


subject: PR:000012938

subject_name: pinin


subject: CHEBI:187893

subject_name: Baclofen

object_name: Hiccough


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: adenosquamous lung carcinoma


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:95021

subject_name: pemetrexed

object_name: lung large cell carcinoma


subject: CHEBI:95021

object_name: minimally invasive lung adenocarcinoma


subject: CHEBI:95021


subject: DRUGBANK:DB14101

subject_name: Soy isoflavones

object_name: Non-small cell lung cancer stage IIIB


subject: DRUGBANK:DB14101

object_name: Non-small cell lung cancer recurrent


subject: DRUGBANK:DB14101

object_name: Non-small cell lung cancer stage IIIA


subject: DRUGBANK:DB14101


subject: DRUGBANK:DB14101

object_name: squamous cell lung carcinoma


subject: DRUGBANK:DB14101


subject: DRUGBANK:DB14101


subject: DRUGBANK:DB14101

object_name: lung adenocarcinoma


subject: CHEBI:9168

object_name: large B-cell lymphoma


subject: UNII:F094Y61748

subject_name: Valomaciclovir

object_name: infectious mononucleosis


subject: CHEBI:233436

subject_name: Tolebrutinib

object_name: multiple sclerosis


subject: DRUGBANK:DB18715


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Avitaminosis


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:71940

subject_name: Tadalafil

object_name: Dyspnea


subject: CHEBI:71940

object_name: Dyspnea, CTCAE


subject: CHEBI:71940

object_name: cardiovascular surgery result: dyspnea


subject: UMLS:C5446887

subject_name: CDK4 Inhibitor PF-07220060

object_name: Childhood Breast Carcinoma


subject: UMLS:C5446887

object_name: breast carcinoma


subject: UMLS:C5446887

object_name: breast cancer


subject: CHEBI:6121

subject_name: Ketamine

object_name: social phobia


subject: CHEBI:124939

subject_name: Rigosertib

object_name: anemia


subject: CHEBI:124939

object_name: Anemia, CTCAE


subject: CHEBI:124939

object_name: myelofibrosis


subject: CHEBI:124939

object_name: leukemia


subject: CHEBI:124939

object_name: childhood leukemia


subject: CHEBI:124939

object_name: Splenomegaly


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: UNII:5TAA004E22

object_name: aplastic anemia


subject: UNII:5TAA004E22

object_name: idiopathic aplastic anemia


subject: UNII:5TAA004E22

object_name: Fanconi anemia


subject: UNII:5TAA004E22

object_name: Fanconi anemia complementation group A


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C5700219

subject_name: Therapeutic allogeneic lymphocytes


subject: UMLS:C5700219


subject: UMLS:C5700219


subject: UMLS:C5700219

object_name: adult lymphoma


subject: UMLS:C5700219

object_name: lymphoma


subject: UMLS:C5700219

object_name: pediatric lymphoma


subject: UMLS:C5700219

object_name: myeloproliferative neoplasm


subject: UMLS:C5700219

object_name: Myelodysplasia


subject: UMLS:C5700219


subject: UMLS:C5700219


subject: UMLS:C5700219


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: thrombophilia due to thrombin defect


subject: PUBCHEM.COMPOUND:92043599

object_name: Venous thrombosis after immobility


subject: PUBCHEM.COMPOUND:129049969

subject_name: tegileridine

object_name: pain agnosia


subject: PUBCHEM.COMPOUND:129049969

object_name: Pain insensitivity


subject: UNII:YFJS8L4TGU

subject_name: TEGILERIDINE


subject: UNII:YFJS8L4TGU


subject: CHEBI:31348

subject_name: Capecitabine

object_name: carcinoma


subject: CHEBI:31348

object_name: squamous cell neoplasm


subject: CHEBI:31348

object_name: anus neoplasm


subject: CHEBI:31348

object_name: anus disorder


subject: CHEBI:25357

subject_name: mitomycin


subject: CHEBI:25357

object_name: squamous cell carcinoma


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357

object_name: neoplasm


subject: UNII:V03E10691T

subject_name: MITOMYCINS


subject: UNII:V03E10691T


subject: UNII:V03E10691T


subject: UNII:V03E10691T


subject: UNII:V03E10691T


subject: UNII:V03E10691T


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: UMLS:C0003299

subject_name: Antiepileptic Agents

object_name: Anoxic Encephalopathy


subject: UMLS:C0003299

object_name: Hypoxic-Ischemic Encephalopathy


subject: UMLS:C0003299

object_name: cardiac arrest


subject: UMLS:C0003299

object_name: Cardiac Arrest, CTCAE


subject: UMLS:C0003299

object_name: Status epilepticus


subject: CHEBI:87631

subject_name: statin

object_name: Out-of-Hospital Cardiac Arrest


subject: CHEBI:9150

subject_name: Simvastatin


subject: PUBCHEM.COMPOUND:74413906

subject_name: Cobalamin

object_name: vitamin B12 deficiency


subject: PUBCHEM.COMPOUND:74413906

object_name: pregnancy related


subject: PUBCHEM.COMPOUND:74413906

object_name: anemia


subject: PUBCHEM.COMPOUND:74413906

object_name: Anemia, CTCAE


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: UMLS:C0086024

subject_name: cobalamins


subject: CHEBI:17439

subject_name: Cyanocobalamin


subject: UMLS:C5666934

subject_name: Oncolytic HSV-1 Expressing IL-12 and Anti-PD-1 Antibody MVR-C5252

object_name: glioblastoma


subject: UMLS:C5666934

object_name: Childhood Glioblastoma


subject: UMLS:C5666934

object_name: adult glioblastoma


subject: UMLS:C5666934

object_name: Brain Stem Glioblastoma


subject: UMLS:C5666934

object_name: glioma susceptibility 1


subject: UMLS:C5666934

object_name: brain glioblastoma


subject: UMLS:C5666934

object_name: Childhood Solid Neoplasm


subject: UMLS:C5666934

object_name: Adult Solid Neoplasm


subject: UMLS:C5666934

object_name: Solid Neoplasm


subject: UMLS:C5446642

subject_name: Anti-CD39 Monoclonal Antibody IPH5201

object_name: non-small cell lung carcinoma


subject: CHEBI:6801

subject_name: Metformin

object_name: metabolic disease


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: CHEBI:6504

object_name: cannabis abuse


subject: CHEBI:6504

object_name: substance withdrawal syndrome


subject: CHEBI:177607

subject_name: Taranabant

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:177607

object_name: obesity


subject: CHEBI:177607

object_name: Obesity, CTCAE


subject: UNII:FZ7NYF5N8L

subject_name: IRON SUCROSE

object_name: Physical trauma


subject: UNII:FZ7NYF5N8L

object_name: Injury


subject: UNII:FZ7NYF5N8L

object_name: Trauma


subject: CHEBI:192761

subject_name: Iron sucrose


subject: CHEBI:192761


subject: CHEBI:192761


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Stage II Diffuse Large B-Cell Lymphoma


subject: CHEBI:63791

object_name: Stage IV Diffuse Large B-Cell Lymphoma


subject: CHEBI:63791

object_name: Stage III Diffuse Large B-Cell Lymphoma


subject: CHEBI:75984

subject_name: Flecainide

object_name: Andersen-Tawil syndrome


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: infertility


subject: CHEBI:26710

subject_name: Sodium chloride


subject: MESH:C000631987

object_name: deafness


subject: MESH:C000631987

object_name: hearing loss by exam


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Dyslipidemia


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:33313

subject_name: polonium atom


subject: UMLS:C5206815

object_name: lung cancer


subject: UMLS:C5206815

object_name: lung neoplasm


subject: UMLS:C5206815

object_name: lung carcinoma


subject: UMLS:C5706368

subject_name: Anti-B7-H3 Antibody-drug Conjugate HS-20093

object_name: Advanced prostate cancer


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: no feeling or sensation of skin


subject: CHEBI:46195

object_name: Sensory Loss


subject: CHEBI:46195

object_name: Postoperative ileus


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: CHEBI:42797

subject_name: Gabapentin


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130

object_name: pain agnosia


subject: CHEBI:9130

object_name: Pain insensitivity


subject: CHEBI:32599


subject: CHEMBL.COMPOUND:CHEMBL2108494

subject_name: INTERFERON

object_name: interstitial cystitis


subject: UMLS:C3652465

subject_name: Interferon


subject: UMLS:C0021747

subject_name: Interferons


subject: UMLS:C0733470

subject_name: human leukocyte interferon


subject: CHEBI:15365

subject_name: Aspirin

object_name: Nonvalvular atrial fibrillation


subject: CHEBI:10033

subject_name: Warfarin


subject: UNII:9H4570Q89D

subject_name: Pleconaril

object_name: common cold


subject: UNII:9H4570Q89D

object_name: Rhinovirus infection


subject: UNII:9H4570Q89D

object_name: asthma


subject: UNII:9H4570Q89D

object_name: Picornaviridae infectious disease


subject: UMLS:C5226856

subject_name: lutikizumab

object_name: osteoarthritis


subject: GTOPDB:13796

subject_name: serplulimab

object_name: Metastatic malignant neoplasm to liver


subject: GTOPDB:13796

object_name: colorectal cancer


subject: GTOPDB:13796

object_name: colorectal carcinoma


subject: GTOPDB:13796

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594550


subject: CHEMBL.COMPOUND:CHEMBL4594550


subject: CHEMBL.COMPOUND:CHEMBL4594550


subject: UMLS:C4745029

subject_name: HLX 10


subject: UMLS:C4745029


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Perinatal intraventricular hemorrhage


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:17234

subject_name: D-glucose


subject: PUBCHEM.COMPOUND:56841998

subject_name: Epoch

object_name: Lymphoma, AIDS-Related


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: MESH:C000718667

subject_name: mastiha

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C1741942

subject_name: Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

object_name: palindromic rheumatism of wrist


subject: UNII:7D0YB67S97

subject_name: Abatacept


subject: PUBCHEM.COMPOUND:57928403

subject_name: peficitinib

object_name: rheumatoid arthritis


subject: UNII:HPH1166CKX

subject_name: Peficitinib


subject: CHEBI:15367

subject_name: Tretinoin

object_name: adult acute myeloid leukemia


subject: CHEBI:15367

object_name: childhood acute myeloid leukemia


subject: CHEBI:51799

subject_name: Imipenem

object_name: Cirrhosis


subject: CHEBI:51799

object_name: liver cirrhosis


subject: CHEBI:190509


subject: CHEBI:190509


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: UMLS:C4721942

subject_name: Oncolytic Ad5-Delta 24RGD

object_name: ovarian cancer


subject: UMLS:C4721942

object_name: ovarian neoplasm


subject: UMLS:C4721942

object_name: ovarian carcinoma


subject: UMLS:C4721942

object_name: primary peritoneal carcinoma


subject: UMLS:C4721942

object_name: Primary Peritoneal Cancer


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: hepatic encephalopathy


subject: CHEBI:46245

object_name: intellectual disability


subject: CHEBI:6712

subject_name: Meclofenoxate


subject: CHEBI:6712


subject: CHEBI:74792

subject_name: Pro-Lys

object_name: Severe infection


subject: CHEBI:60948


subject: UMLS:C0034348

subject_name: Pyruvate Kinase


subject: PR:000009420

subject_name: plasma kallikrein


subject: UniProtKB:P14272

subject_name: KLKB1_RAT Plasma kallikrein (sprot)


subject: UMLS:C0312957

subject_name: Blood group antigen p k


subject: PUBCHEM.COMPOUND:146219790

subject_name: atirmociclib

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:146219790

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:146219790

object_name: breast cancer


subject: PUBCHEM.COMPOUND:146219790

object_name: Advanced cancer


subject: PUBCHEM.COMPOUND:146219790

object_name: PIK3CA Gene Mutation


subject: PUBCHEM.COMPOUND:146219790

object_name: PI3K Gene Mutation


subject: UMLS:C5966116

subject_name: Atirmociclib


subject: UMLS:C5966116


subject: UMLS:C5966116


subject: UMLS:C5966116


subject: UMLS:C5966116


subject: UMLS:C5966116


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: UMLS:C5961091

subject_name: Mutant-selective PI3K-alpha H1047R Inhibitor OKI-219


subject: UMLS:C5961091


subject: UMLS:C5961091


subject: UMLS:C5961091


subject: UMLS:C5961091


subject: UMLS:C5961091


subject: CHEBI:230905

subject_name: Ribociclib


subject: CHEBI:230905


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UNII:234248D0HH

subject_name: Tucatinib


subject: UNII:234248D0HH


subject: UNII:234248D0HH


subject: CHEBI:61080

subject_name: Romidepsin

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:61080

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:61080

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C1268859

subject_name: Zinc supplement

object_name: hepatitis C


subject: CHEBI:74947

subject_name: Thalidomide

object_name: systemic sclerosis


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: endometrium adenocarcinoma


subject: CHEBI:175901

object_name: endometrial clear cell adenocarcinoma


subject: CHEBI:175901

object_name: endometrial adenosquamous carcinoma


subject: UMLS:C1705207

subject_name: Endostar

object_name: Adverse effect of radiation therapy


subject: UMLS:C0003233

subject_name: Antibiotics, Aminoglycoside

object_name: Prosthetic valve endocarditis


subject: CHEBI:47779

subject_name: aminoglycoside


subject: UMLS:C3536835

subject_name: Aminoglycoside [EPC]


subject: CHEBI:229221

subject_name: Fruquintinib

object_name: Malignant neoplasm of colon stage IV


subject: UNII:DOB7Y3RSX0

subject_name: HPPH

object_name: Neck Carcinoma


subject: UNII:DOB7Y3RSX0

object_name: head and neck neoplasm


subject: UNII:DOB7Y3RSX0

object_name: head and neck cancer


subject: CHEBI:49575

subject_name: Diazepam

object_name: Post-Operative Pain


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: acute leukemia


subject: CHEBI:8884

subject_name: Rocuronium

object_name: carcinoma of esophagus


subject: CHEBI:8884

object_name: esophageal cancer


subject: CHEBI:8884

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:8884

object_name: neoplasm of esophagus


subject: CHEBI:15765

subject_name: Levodopa

object_name: blindness


subject: CHEBI:15765

object_name: Impaired Vision


subject: UMLS:C0795571

subject_name: amphetamine-dextroamphetamine

object_name: recurrent hypersomnia


subject: UMLS:C0795571

object_name: idiopathic hypersomnia


subject: UMLS:C0795571

object_name: narcolepsy without cataplexy


subject: UNII:43VB0F6WF9

subject_name: BOVHYALURONIDASE AZOXIMER

object_name: lower urinary tract symptom


subject: UNII:43VB0F6WF9

object_name: benign prostatic hyperplasia


subject: UMLS:C5419297

subject_name: Bovhyaluronidase azoximer


subject: UMLS:C5419297


subject: UMLS:C1135138

object_name: Carcinoma breast stage IV


subject: UMLS:C1135138

object_name: breast neoplasm


subject: UMLS:C2830207

object_name: metastatic colorectal cancer


subject: GTOPDB:9421

subject_name: itolizumab

object_name: graft versus host disease


subject: GTOPDB:9421

object_name: acute graft versus host disease


subject: UNII:XQQ2RHV14N


subject: UNII:XQQ2RHV14N


subject: UMLS:C2987424


subject: UMLS:C2987424


subject: CHEBI:94573

subject_name: Zibotentan

object_name: coronary microvascular disorder


subject: CHEBI:600103

subject_name: daptomycin

object_name: meningitis


subject: CHEBI:600103

object_name: Meningitis, CTCAE


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Hyperthermia


subject: PUBCHEM.COMPOUND:14907381

object_name: Fever


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: fallopian tube neoplasm


subject: UMLS:C3884993

subject_name: AMG 181

object_name: Crohn disease


subject: UMLS:C2973912

subject_name: TAK 442

object_name: acute coronary syndrome


subject: CHEBI:7465

subject_name: Naltrexone

object_name: corneal ulcer


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Addiction


subject: UMLS:C3641863

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: hematopoietic and lymphoid cell neoplasm


subject: PUBCHEM.COMPOUND:135512673

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:135512673

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: HMDB:HMDB0015179


subject: CHEBI:61080

subject_name: Romidepsin


subject: CHEBI:61080


subject: CHEBI:61080


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: PUBCHEM.COMPOUND:2781

subject_name: Meclastine

object_name: internuclear ophthalmoplegia


subject: CHEBI:3738

subject_name: Clemastine


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: delirium


subject: UMLS:C1527137

object_name: Delirium, CTCAE


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: UMLS:C5139677

object_name: Carcinoma breast stage IV


subject: UMLS:C5139677

object_name: Secondary malignant neoplasm of lung


subject: UMLS:C5139677

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:149520

subject_name: Polihexanide

object_name: ORAL SURGICAL WOUND INFECTION


subject: CHEBI:149520

object_name: periodontal disorder


subject: CHEBI:149520

object_name: Peri-Implantitis


subject: CHEBI:149520

object_name: Dental Plaque


subject: CHEBI:149520

object_name: dental caries


subject: CHEBI:149520

object_name: Caries (morphologic abnormality)


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:3614


subject: CHEBI:3614


subject: CHEBI:49746

object_name: prostate carcinoma


subject: CHEBI:49746

object_name: prostate cancer


subject: CHEBI:49746

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:49746

object_name: prostate disorder


subject: CHEBI:49746

object_name: prostate neoplasm


subject: CHEBI:49746

object_name: Neoplasm of the genitourinary tract


subject: CHEBI:33382

subject_name: lutetium atom


subject: CHEBI:33382


subject: CHEBI:33382


subject: CHEBI:33382


subject: CHEBI:33382


subject: CHEBI:33382


subject: UNII:BRH40Y9V1Q

subject_name: Lutetium Lu-177


subject: UNII:BRH40Y9V1Q


subject: UNII:BRH40Y9V1Q


subject: UNII:BRH40Y9V1Q


subject: UNII:BRH40Y9V1Q


subject: UNII:BRH40Y9V1Q


subject: UMLS:C0718234

subject_name: Acthar

object_name: keratitis


subject: UMLS:C0718234

object_name: Keratitis, CTCAE


subject: CHEBI:62880

subject_name: Veliparib

object_name: pancreatic neoplasm


subject: CHEBI:62880

object_name: exocrine pancreatic carcinoma


subject: CHEBI:62880

object_name: malignant pancreatic neoplasm


subject: CHEBI:94463

object_name: Crimean-Congo hemorrhagic fever


subject: CHEBI:63580

subject_name: Ribavirin


subject: PUBCHEM.COMPOUND:6435378

subject_name: iloprost

object_name: Ayerza's syndrome


subject: CHEBI:52970

object_name: Increased reactive oxygen species production


subject: CHEBI:52970

object_name: Inflammation


subject: CHEBI:52970

object_name: muscle injury


subject: CHEBI:60899


subject: CHEBI:60899


subject: CHEBI:60899


subject: CHEBI:177490


subject: CHEBI:177490


subject: CHEBI:177490


subject: CHEBI:167578


subject: CHEBI:167578


subject: CHEBI:167578


subject: CHEBI:64183

subject_name: Ubiquinol


subject: CHEBI:64183


subject: CHEBI:64183


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: Multiple Pulmonary Nodules


subject: UMLS:C3540708

object_name: pulmonary coin lesion


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: MESH:D000904


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540709


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C3540707


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540704


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540706


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540710


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C3540705


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: Hyperkalemia, CTCAE


subject: MESH:D002136

object_name: Hyperkalemia


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UMLS:C3540037


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: UNII:WY779SQ0XW


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:29108


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:22984


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C2936886


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: UMLS:C3714611


subject: UMLS:C4055163

object_name: Stomach cancer


subject: UMLS:C4055163

object_name: gastric cancer


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: UMLS:C0879373

subject_name: Iodinated Contrast Agent

object_name: liver cancer


subject: UMLS:C0879373

object_name: liver neoplasm


subject: UMLS:C0879373

object_name: Adult Liver Carcinoma


subject: UMLS:C0879373

object_name: liver carcinoma


subject: CHEBI:50162

subject_name: motexafin gadolinium hydrate


subject: CHEBI:50162


subject: CHEBI:50162


subject: CHEBI:50162


subject: PUBCHEM.COMPOUND:9919910

subject_name: Xcytrin


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: CHEBI:33375

subject_name: Gadolinium


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEMBL.COMPOUND:CHEMBL3544910

subject_name: MOTEXAFIN GADOLINIUM


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: PUBCHEM.COMPOUND:6435378

subject_name: iloprost

object_name: cardiac arrest


subject: PUBCHEM.COMPOUND:6435378

object_name: Cardiac Arrest, CTCAE


subject: UMLS:C0027866

subject_name: Neuromuscular Blocking Agents

object_name: adult acute respiratory distress syndrome


subject: CHEBI:36704

subject_name: Imiquimod

object_name: malignant glioma


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Dysesthesia


subject: CHEBI:42797

object_name: Bilateral cataracts (disorder)


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: traumatic encephalopathy


subject: CHEBI:27812

object_name: traumatic brain injury


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: Refractory Neuroblastoma


subject: PR:000005931


subject: UNII:TL60C27RLH

subject_name: Metreleptin

object_name: Overweight


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:73005958

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:73005958

object_name: Miller-Dieker lissencephaly syndrome


subject: PUBCHEM.COMPOUND:73005958

object_name: myoclonic dystonia 11


subject: PUBCHEM.COMPOUND:73005958

object_name: acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:73005958

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: PUBCHEM.COMPOUND:73005958

object_name: Blast Phase


subject: PUBCHEM.COMPOUND:73005958

object_name: Blastic Phase


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: UMLS:C4722537

subject_name: TG02 Citrate


subject: UMLS:C4722537


subject: UMLS:C4722537


subject: UMLS:C4722537


subject: UMLS:C4722537


subject: UMLS:C4722537


subject: UMLS:C4722537

object_name: plasma cell myeloma


subject: UMLS:C4722537


subject: UMLS:C4722537


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: migraine


subject: CHEBI:60648

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:60648

object_name: migraine with aura


subject: CHEBI:60648

object_name: Common Migraine


subject: CHEBI:60648

object_name: hypnic headache


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: UMLS:C1567966

subject_name: Triptans


subject: UMLS:C1567966


subject: UMLS:C1567966


subject: UMLS:C1567966


subject: UMLS:C1567966


subject: UMLS:C0162754

subject_name: Serotonin 5-HT1 Receptor Agonists


subject: UMLS:C0162754


subject: UMLS:C0162754


subject: UMLS:C0162754


subject: UMLS:C0162754


subject: UMLS:C4289970

subject_name: Anti-PD1 Monoclonal Antibody

object_name: Gastroesophageal junction cancer


subject: UMLS:C4289970

object_name: gastric adenocarcinoma


subject: UMLS:C3658787

object_name: bladder tumor


subject: UMLS:C3658787

object_name: urinary bladder carcinoma


subject: UMLS:C3658787

object_name: urinary bladder cancer


subject: UMLS:C3658787

object_name: childhood bladder carcinoma


subject: PUBCHEM.COMPOUND:23581792

subject_name: IRINOTECAN HYDROCHLORIDE HYDRATE

object_name: metastatic colorectal cancer


subject: CHEBI:90881

subject_name: Camptosar


subject: UMLS:C4760648


subject: UMLS:C2342719

subject_name: calcium levofolinate


subject: CHEBI:9144

subject_name: Silibinin

object_name: acne


subject: CHEBI:125451

subject_name: silymarin


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:1805

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:1805

object_name: digestive system cancer


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEMBL.COMPOUND:CHEMBL2109300

object_name: Alzheimer disease


subject: CHEBI:6456

subject_name: Lidocaine

object_name: vulvodynia


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:63618

subject_name: Pravastatin

object_name: postmenopausal osteoporosis


subject: UMLS:C2346883

subject_name: Autologous Dendritic Cell-Tumor Fusion Vaccine

object_name: skin melanoma


subject: PUBCHEM.COMPOUND:11650937

subject_name: Capiri


subject: UMLS:C3489692

subject_name: CAPIRI


subject: CHEBI:177387

subject_name: Brequinar

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:177387

object_name: acute myeloid leukemia


subject: UMLS:C1512511

subject_name: Human Papilloma Virus Vaccine

object_name: rubella


subject: UMLS:C1512511

object_name: mumps


subject: UMLS:C1512511

object_name: measles


subject: UMLS:C1512511

object_name: human papilloma virus infection type 16


subject: UMLS:C1512511

object_name: human papilloma virus infection type 18


subject: PUBCHEM.COMPOUND:91973920

subject_name: Grape Seed P.E.

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:91973920

object_name: coronary atherosclerosis


subject: MESH:D056604

subject_name: Grape Seed Extract


subject: MESH:D056604


subject: DRUGBANK:DB16606

subject_name: Vitis vinifera seed


subject: DRUGBANK:DB16606


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: PUBCHEM.COMPOUND:71296095

subject_name: Sarecycline Hydrochloride

object_name: Chapped lip


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Recurrence


subject: CHEBI:175901

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:175901

object_name: Recurrent disease


subject: CHEBI:175901

object_name: Recurrent tumor


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: hantavirus infectious disease


subject: CHEBI:35181

object_name: Carcinoma breast stage IV


subject: CHEBI:35181

object_name: Her2-receptor negative breast cancer


subject: CHEBI:35181

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: CHEBI:18198

subject_name: 4-amino-4-deoxychorismic acid


subject: CHEBI:18198


subject: CHEBI:18198


subject: CHEBI:157780

subject_name: S-Cysteinosuccinic acid


subject: CHEBI:157780


subject: CHEBI:157780


subject: PR:000022058

subject_name: biodegradative arginine decarboxylase


subject: PR:000022058


subject: PR:000022058


subject: PR:000007791

subject_name: acidic amino acid decarboxylase GADL1


subject: PR:000007791


subject: PR:000007791


subject: PR:000023971

subject_name: biosynthetic arginine decarboxylase


subject: PR:000023971


subject: PR:000023971


subject: UniProtKB:Q7NSA6

subject_name: ADC_CHRVO Acetoacetate decarboxylase (sprot)


subject: UniProtKB:Q7NSA6


subject: UniProtKB:Q7NSA6


subject: PR:000032161

subject_name: antizyme inhibitor 2


subject: PR:000032161


subject: PR:000032161


subject: UniProtKB:D4A693

subject_name: AZIN2_RAT Antizyme inhibitor 2 (sprot)


subject: UniProtKB:D4A693


subject: UniProtKB:D4A693


subject: CHEBI:35469

subject_name: antidepressant

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:35469

object_name: Back pain


subject: CHEBI:35469

object_name: Back Pain, CTCAE 3.0


subject: UMLS:C0003289

subject_name: Antidepressive Agents


subject: UMLS:C0003289


subject: UMLS:C0003289


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist

object_name: Endometrioma


subject: UMLS:C0112708

subject_name: Trelstar


subject: UMLS:C4727690

object_name: Overweight


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Muscle mass


subject: CHEBI:89324

object_name: Sarcopenic obesity


subject: CHEBI:89324

object_name: vitamin D hydroxylation-deficient rickets, type 1B


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Coronavinae infectious disease


subject: UNII:082285VIDF

subject_name: fluoromisonidazole

object_name: malignant glioma


subject: UNII:8MSY49469G

subject_name: Fluoromisonidazole F-18


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: periodontal disorder


subject: PUBCHEM.COMPOUND:18772499

object_name: Periodontal Pocket


subject: PUBCHEM.COMPOUND:18772499

object_name: periodontitis


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin